Friday, February 1, 2019

U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter earnings fell below analysts' forecasts.


from Reuters: Health News https://reut.rs/2GdI29W

Related Posts:

  • LATEST HEALTH NEWSOne type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms from Health http://ift.tt/2HDOvbR … Read More
  • LATEST HEALTH NEWSIn summers, depending upon conditions and circumstances one can incorporate both outdoor and indoor activities in their training schedule. from Health http://ift.tt/2DwgR5v … Read More
  • LATEST HEALTH NEWSResearchers found that people with low grip strength had weaker hearts that were less able to pump blood from Health http://ift.tt/2FOJT1Y … Read More
  • LATEST HEALTH NEWSThe ageing cyclists had almost as many new T cells in their blood as did the young people from Health https://ift.tt/2piYoUI … Read More
  • LATEST HEALTH NEWSCOPENHAGEN (Reuters) - Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the Danish drugmaker said on Friday. from Reuters: Health News… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner